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Purdue University
The accurate quantification of gene expression levels is crucial for
transcriptome study. Microarray platforms are commonly used for si-
multaneously interrogating thousands of genes in the past decade,
and recently RNA-Seq has emerged as a promising alternative. The
gene expression measurements obtained by microarray and RNA-Seq
are, however, subject to various measurement errors. A third platform
called qRT-PCR is acknowledged to provide more accurate quantifi-
cation of gene expression levels than microarray and RNA-Seq, but
it has limited throughput capacity. In this article, we propose to use
a system of functional measurement error models to model gene ex-
pression measurements and calibrate the microarray and RNA-Seq
platforms with qRT-PCR. Based on the system, a two-step approach
was developed to estimate the biases and error variance components
of the three platforms and calculate calibrated estimates of gene ex-
pression levels. The estimated biases and variance components shed
light on the relative strengths and weaknesses of the three platforms
and the calibrated estimates provide a more accurate and consistent
quantification of gene expression levels. Theoretical and simulation
studies were conducted to establish the properties of those estimates.
The system was applied to analyze two gene expression data sets from
the Microarray Quality Control (MAQC) and Sequencing Quality
Control (SEQC) projects.
1. Introduction. The transcriptome of a cell is the entire set of mRNA
molecules or transcripts produced by DNA transcription under certain bi-
ological or environmental conditions. Systematic profiling of the transcrip-
tome cannot only provide a dynamic characterization of the cell’s molecular
constitution, but also shed light on gene functional annotation, regulatory
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mechanisms and transcriptional networks underlying various biological pro-
cesses of the cell.
Since the mid-1990s, DNA microarray has served as the leading exper-
imental platform for transcriptome study [Schena et al. (1995), Lockhart
et al. (1996)]. Despite its huge success, microarray is known to suffer from
some limitations such as reliance on existing knowledge of transcript se-
quences, high level background noise and limited dynamic range of detec-
tion.
A second platform called the quantitative real-time Reverse Transcription
Polymerase Chain Reaction (qRT-PCR) can also be used in gene expression
studies. Although well acknowledged as the most reliable gene expression
measurement technology, the throughput of qRT-PCR is low, that is, the
number of genes or transcripts that can be measured in a single qRT-PCR
experiment is limited. In addition, qRT-PCR is also subject to variations
caused by various biological, technical and experimental factors involved in
qRT-PCR experiments [Bustin (2002), Bustin and Nolan (2004)]. Currently,
qRT-PCR is used either for detecting and quantifying a small number of spe-
cific transcript targets or as a gold standard for validating hits or findings
from other high-throughput platforms such as microarray [Applied Biosys-
tems (2006)].
Recently, RNA-Seq has emerged as a new experimental platform for tran-
scriptome profiling, and it is believed to overcome the major limitations of
microarray [Wang, Gerstein and Snyder (2009)]. Although promising, data
generated from RNA-Seq experiments still demonstrate excessive variabil-
ity [Schwartz, Oren and Ast (2011)]. Therefore, RNA-Seq data need to be
normalized before used in downstream transcriptome analysis. A number
of methods have been proposed in the literature for normalizing RNA-Seq
data, including RPKM [Mortazavi et al. (2008)], quantile-based procedures
[Bullard et al. (2010)], TMM [Robinson and Oshlack (2010)], mseq [Li, Jiang
and Wong (2010)], GPseq [Srivastava and Chen (2010)], POME [Hu et al.
(2012)] and DESeq [Anders and Huber (2010)]. Nonetheless, the problem
of how to statistically characterize and normalize RNA-Seq data has not
been fully settled with satisfaction and demands further investigation [Mak
(2011)].
The strengths and weaknesses of qRT-PCR, RNA-Seq and microarray can
be summarized as follows. In terms of throughput capacity, RNA-Seq is the
highest, microarray is the second, and qRT-PCR is the lowest, whereas, in
terms of accuracy, the order from the highest to the lowest is qRT-PCR,
RNA-Seq and microarray. An ideal platform for transcriptome profiling
should combine the accuracy of qRT-PCR with the high-throughput capac-
ity of RNA-Seq. Unfortunately, such a platform is not currently available
yet. A natural question is whether it is possible to use statistical methods
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to combine the strengths of the three platforms and generate gene expres-
sion measurements of a higher quality at the genome-wide scale. The answer
turns out to be positive, and the methodology that can be applied is statis-
tical calibration.
Statistical calibration is typically used for the scenario where p instru-
ments are available for measuring the same quantity. Among the instru-
ments, one is more accurate but at the same time more expensive than the
others. In order to make a less accurate instrument generate more reliable
measurement results for general use, it needs to be calibrated by the most ac-
curate instrument through statistical analysis. There are two different types
of calibration, which are absolute calibration and comparative calibration.
Absolute calibration assumes the most accurate instrument gives the true
value of the targeted quantity, whereas comparative calibrate assumes the
most accurate instrument is also subject to measurement error. The liter-
ature on statistical calibration is primarily focused on absolute calibration,
and a variety of statistical methods have been developed; see Osborne (1991)
for a comprehensive review. On the other hand, comparative calibration is
more challenging than absolute calibration and is mainly discussed in the
literature on measurement error models; see Fuller (1987) and Cheng and
Van Ness (1999) for more thorough discussions.
The platforms for measuring gene expression levels using qRT-PCR, mi-
croarray and RNA-Seq represent three different instruments, with the qRT-
PCR platform being the most accurate and the most expensive. In this
article, we propose to use a system of measurement error (ME) models to
model gene expression measurements obtained by the qRT-PCR, microarray
and RNA-Seq platforms, and to further use the system to calibrate RNA-Seq
and microarray measurements with qRT-PCRmeasurements. A two-step ap-
proach is used to estimate the parameters of the system of ME models, and
the statistical properties of the resulting estimates are discussed. Through
both theoretical and simulation studies, we show that the calibrated gene
expression measurements are more consistent and accurate than those by
any of the individual platforms. Furthermore, we apply the system of ME
models to calibrate gene expression data generated by qRT-PCR, RNA-Seq
and microarray from both the Microarray Quality Control (MAQC) and Se-
quencing Quality Control (SEQC) projects (detailed information about the
data is given in Section 4.1), and show that the resulting calibrated mea-
surements provide more accurate quantification of gene expression levels and
lead to more discoveries in gene differential expression analysis.
In Section 2 we define the system of measurement error (ME) models and
describe the two-step approach for estimating the parameters in the system.
In Section 3 we present some simulation results. In Section 4 we describe
the gene expression data from the MAQC and SEQC projects and discuss
the results from applying the system of ME models to analyze the data.
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Section 5 concludes the article with further discussion and possible future
research.
2. Measurement error models and calibration. Let T denote the collec-
tion of all the genes or transcripts in the transcriptome under study. As dis-
cussed in the Introduction, RNA-Seq has the capacity to measure the expres-
sion levels of all genes in T , microarray can target thousands of genes, and
qRT-PCR generally will measure at most hundreds of genes in a single ex-
periment. Let A, B and C be the collections of genes measured by qRT-PCR,
microarray and RNA-Seq, respectively. We assume that A⊂B ⊂ C ⊂ T , and
the cardinalities of A, B and C are n, m and l, respectively. By the assump-
tion, n genes (i.e., those in A) are measured by all three platforms, m− n
genes (i.e., those in B − A) are measured by both microarray and RNA-
Seq, and l−m genes (i.e., those in C −B) are measured only by RNA-Seq.
We further assume that commonly used platform-specific methods are used
to process and normalize raw data generated by each platform to produce
gene expression measurement data. Some examples are the PLIER method
[Affymetrix Inc. (2005)] for microarray, the RPKM method for RNA-Seq
and the delta–delta Ct method for qRT-PCR. Following the convention in
transcriptome studies, the log-2 transformation is further applied to the nor-
malized gene expression measurements of the three platforms, and we refer
to the resulting normalized transformed values as the qRT-PCR, microarray
and RNA-Seq gene expression measurements, respectively, in the rest of this
article.
Each type of gene expression measurement data can be generated by one
lab or multiple labs. Based on the number of labs involved in generating one
type of gene expression measurement data, we distinguish two scenarios,
which are the single-lab scenario and the multi-lab scenario. In the single-
lab scenario, each type of gene expression measurement data (e.g., RNA-Seq
data) is generated by a single lab. However, the expression measurement data
of different types are not necessarily generated from the same lab. In the
multi-lab scenario at least one type of gene expression data is generated by
more than one lab. Due to limited space, we treat only the single-lab scenario
in this section, and the multi-lab scenario will be discussed in Section S.7 of
the supplementary material [Sun, Kuczek and Zhu (2014)].
2.1. Single-lab scenario. Suppose that the genes in A, B −A and C −B
are labeled by integers from 1 to n, n+1 to m, and m+1 to l, respectively.
We assume each platform generates one expression measurement for each
gene. When technical replicates are available, their average value is used
as the expression measurement of a gene. For 1≤ j ≤ n, let Xj denote the
expression measurement of gene j by qRT-PCR. Similarly, let Yj denote the
expression measurement of gene j by microarray for 1≤ j ≤m, and Zj the
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expression measurement of gene j by RNA-Seq for 1≤ j ≤ l. Note that Xj ,
Yj and Zj are all in log-2 scales.
As discussed in the Introduction, gene expression measurements produced
by the three platforms are all subject to measurement errors. We propose
to use the following measurement error models to characterize Xj , Yj and
Zj , respectively,
Xj = µj + ε1j (1≤ j ≤ n),(2.1a)
Yj = α2 + β2µj + ε2j (1≤ j ≤m),(2.1b)
Zj = α3 + β3µj + ε3j (1≤ j ≤ l).(2.1c)
The above models are not simple linear models because none of the terms
on the right-hand sides of the equations is observed, and terms β2µj and
β3µj are cross terms of unknown quantities. Note that n < m < l, that is,
the three platforms measure different subsets of genes. Next, we will discuss
the terms in these three models in detail and then propose the estimation
method.
In model (2.1a), µj is the true expression level of gene j and ε1j is the ran-
dom error due to the qRT-PCR platform. Depending on the normalization
method, qRT-PCR can lead to either absolute quantitation or relative quan-
titation of a gene’s expression level [Pfaffl (2004), Chapter 3]. Therefore, the
interpretation of µj depends on whether absolute or relative quantitation
is used in an experiment. For simplicity, in this article, we do not further
distinguish these two quantitation methods and simply refer to µj as the
true expression value of gene j. We assume that for 1≤ j ≤ n, ε1j ’s are i.i.d.
N(0, σ21). The variance of Xj is σ
2
1 , representing the reproducibility of the
qRT-PCR platform. According to the model, the qRT-PCR measurement
Xj is unbiased with respect to µj .
In model (2.1b), ε2j is the random error due to the microarray platform.
For 1 ≤ j ≤ m, we assume ε2j ’s are i.i.d. N(0, σ22). The other two terms
gives the mean measurement, that is, E(Yj) = α2 + β2µj . In other words,
the expectation of the microarray measurement of gene j is assumed to
be a linear function of µj , where α2 and β2 are the intercept and slope,
respectively. The variance of Yj is σ
2
2 . Note that due to the differences in
technologies and platform specific normalization methods, gene expression
measurements from different platforms are in different scales and may have
shifts. Therefore, α2 and β2 represent the shift and scale of the microarray
measurements relative to the qRT-PCR measurements. When comparing
the reproducibilities of the qRT-PCR and microarray platforms, Yj needs
to be transformed to Y˜j = (Yj − α2)/β2, which is of the same scale as Xj .
The variance of Y˜j , which is σ
2
2/β
2
2 , is referred to as the reproducibility of
the microarray platform.
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In model (2.1c), the mean of the RNA-Seq measurement is also assumed to
be a linear function of µj , that is, E(Zj) = α3+β3µj , and ε3j is the random
error due to the RNA-Seq platform. We assume that for 1≤ j ≤ l, ε3j ’s are
i.i.d. N(0, σ23). The intercept α3 and the slope β3 represent the shift and
scale of RNA-Seq measurements relative to the qRT-PCR measurements.
The variance of Zj is σ
2
3 . Similar to the microarray platform, we refer to
σ23/β
2
3 as the reproducibility of the RNA-Seq platform.
Different measurement platforms generally have different dynamic ranges
of detection. This is also the case for the qRT-PCR, microarray and RNA-
Seq platforms. The models proposed above may hold for only a range that
fits all three platforms. Therefore, when applying the models in practice,
a proper range of expression levels needs to be used, and genes with ex-
tremely low or high expression levels need to be excluded. Random mea-
surement errors are typically heteroscedastic, that is, the variance of a ran-
dom measurement error depends on the magnitude of the targeted quantity.
Notice that the errors in the models above are assumed to homoscedastic.
The justification for assuming homoscedastic errors is twofold. First, the
gene expression measurements Xj , Yj and Zj are the log-2 values of the
original measurements produced by the three platforms, respectively, and
the log-2 transformation is known to mitigate heteroscedasticity. Second,
as previously discussed, the proposed models will be applied to genes with
expression levels within a certain proper range, which further alleviates the
concern of heteroscedasticity. Nonetheless, when applying the models, diag-
nostic analysis always needs to be performed.
When µj ’s in models (2.1a)–(2.1c) are assumed to be unknown fixed quan-
tities, the measurement error models are said to be functional ; and when µj ’s
are assumed to be i.i.d. random variables, the models are said to be struc-
tural. In this article, µj ’s are gene expression values and considered fixed.
Therefore, the models defined above are functional. Following the conven-
tion in the literature, we call the µj ’s incidental parameters k and the other
parameters (αi, βi for 2≤ i≤ 3, and σ2i for 1≤ i≤ 3) structural parameters.
In general, when p measurement platforms or instruments are used to
measure the same quantity, it requires p measurement error models to char-
acterize the measurement results. For ease of discussion, the p measurement
error models are said to form a system of ME models of order p. When the
measurement error models are structural, the system is said to be structural;
and when the models are functional, the system is said to be functional.
Hence, models (2.1a)–(2.1c) defined above form a functional system of order
3, and any two of them form a functional system of order 2.
2.2. Parameter estimation. The statistical literature on measurement
error models is focused primarily on systems of order 2. Reiersøl (1950)
showed that structural systems of order 2 are not identifiable under the nor-
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mality assumption, unless additional information such as the ratio between
the variances of the two measurement instruments is available. For struc-
tural systems of order higher than 2 (e.g., p = 3), Barnett (1969) showed
they become identifiable with no further information needed, and the max-
imum likelihood estimates (MLEs) of the structural parameters can be ob-
tained.
Parameter estimation for functional systems of ME models is more diffi-
cult than that for structural systems due to the presence of the incidental
parameters, µj ’s. First, under the normality assumption on the involved
measurement errors, the likelihood function of a functional system becomes
unbounded [Kendall and Stuart (1973)]. Solari (1969) showed that the like-
lihood function of a functional system of order 2 does not have a local
maximum. We have found that this is also generally true for functional sys-
tems of order 3. Therefore, the maximum likelihood method fails to produce
proper estimates for both structural and incidental parameters of a func-
tional system of ME models.
The relationship between structural and functional systems was discussed
in the early literature on measurement error models. Much attention has
been given to the connection between the identifiability of structural sys-
tems and the existence of proper estimates of the structural parameters in
functional systems. Gleser (1983) showed that when a structural system is
identifiable, consistent estimates of the structural parameters in the corre-
sponding functional model exist. Further, he suggested that in most cases,
a good way to find a consistent estimator for the functional model is to
directly verify whether the consistent estimator in the structural model is
also consistent in the corresponding functional model.
Based on the discussion above, a two-step approach can be used to esti-
mate the parameters of the functional system of order 3 defined above for
the qRT-PCR, microarray and RNA-Seq measurements. In the first step, the
genes with measurements from all three platforms (i.e., genes in A) are used
to obtain the MLEs of the structural parameters under the assumption that
these µj ’s are i.i.d. N(µ,σ
2). In the second step, the estimates obtained in
the first step are used in place of their corresponding structural parameters
in the functional ME system, and then the generalized least squares method
is used to obtain estimates of the incidental parameters (or gene expression
levels).
Structural parameters. We use the expression measurements of the genes
inA to estimate the structural parameters. LetX ., Y . and Z . be the averages
of Xj , Yj and Zj over all genes in A. The sample variances and covariances
for {Xj}1≤j≤n, {Yj}1≤j≤n and {Zj}1≤j≤n are denoted as Sxx, Syy, Szz, Sxy, Sxz
and Syz , respectively. Following the first step of the two-step approach dis-
cussed previously, the estimates of the structural parameters are given as
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follows:
βˆ2 =
Syz
Sxz
, βˆ3 =
Syz
Sxy
, αˆ2 = Y . − βˆ2X .,
(2.2a)
αˆ3 = Z . − βˆ2X .,
σˆ21 =
(
Sxx − SxySxz
Syz
)
, σˆ22 =
(
Syy − SxySyz
Sxz
)
,
(2.2b)
σˆ23 =
(
Szz − SyzSxz
Sxy
)
.
Note that when deriving the above estimates, the nonnegativity constraints
on the variance estimates were not enforced due to two considerations. First,
we can enforce the constraints by using more complicated estimates such as
the ones given in Carter and Fuller (1980). However, in practice, the con-
straints are usually satisfied automatically and, thus, the benefit of using
the more complicated estimates is minimal. Second, gene expression data
are often noisy, and the true values of the variance components are unlikely
to be close to 0. The violation of the constraints by the variance components
estimates indicates either the estimates are not reliable due to insufficient
sample size or the model assumptions are invalid and need to be recon-
sidered. The enforcement of the constraints may miss the opportunity of
identifying these potential pitfalls.
For convenience, let θ = (α2, α3, β2, β3, σ
2
1 , σ
2
2, σ
2
3)
⊤ be the vector of the
structural parameters and θˆ the estimate of θ. The following proposition
establishes the asymptotic distribution of θˆ under the functional system of
ME models as n goes to ∞.
Proposition 1. Assume the functional system of ME models is true
and the following limits exist,
µ¯= lim
n→∞
1
n
n∑
j=1
µj and ∆= lim
n→∞
1
n
n∑
j=1
(µj − µ¯)2 > 0.(2.3)
Then, as n goes to ∞, √n(θˆ− θ) D−→N(0,Γθ), where D−→ means converge
in distribution and Γθ is the variance–covariance matrix with its explicit ex-
pression given in the supplementary material [Sun, Kuczek and Zhu (2014)],
Section S.1.2.
The proof of Proposition 1 is outlined in Section S.1.1 of the supplemen-
tary material [Sun, Kuczek and Zhu (2014)]. The assumptions on the mean
and variance of µj ’s in Proposition 1 appear to be reasonable, because µj ’s
are the true expression levels of genes in a given cell line or tissue sample.
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Note that ∆ appears in the denominator of the variances of αˆ2, αˆ3, βˆ2 and
βˆ3. Therefore, the estimates of the structural parameters will attain higher
accuracy when µj ’s in A are more spread out. The asymptotic property of
θˆ is stated as n goes to ∞. In practice, this property will hold approxi-
mately when n is sufficiently large. In our simulation study, we found that
when n ≥ 150, the Mean Square Errors (MSE) of θˆ are close to zero (see
Figure S1 and Figure S2 in the supplementary material [Sun, Kuczek and
Zhu (2014)], Section S.4) and the standard errors of θˆ are within 10% of the
true parameter values.
Incidental parameters. How to best estimate the incidental parameter µj
depends on whether gene j is in A, B−A or C −B. We consider these three
cases separately. For each case, we follow the second step of the two-step
approach discussed previously. First, we replace the structural parameters
by their estimates, and then we apply the generalized least squares method
to obtain the estimate of µj .
Depending on whether gene j is in A, B−A or C−B, given the structural
parameters, the measurement error models involving µj can be rewritten as
a linear model of µj (see the supplementary material [Sun, Kuczek and
Zhu (2014)], Section S.2). Replacing the structural parameters θ by their
estimates θˆ and applying the generalized least squares method, the estimates
of µj for j in A, B −A and C − B are given as follows:
µˆxyzj =
Xj/σˆ
2
1 + βˆ2(Yj − αˆ2)/σˆ22 + βˆ3(Zj − αˆ3)/σˆ23
1/σˆ21 + βˆ
2
2/σˆ
2
2 + βˆ
2
3/σˆ
2
3
for j ∈A;(2.4a)
µˆyzj =
βˆ2(Yj − αˆ2)/σˆ22 + βˆ3(Zj − αˆ3)/σˆ23
βˆ22/σˆ
2
2 + βˆ
2
3/σˆ
2
3
for j ∈ B −A;(2.4b)
µˆzj = (Zj − αˆ3)/βˆ3 for j ∈ C − B.(2.4c)
We call µˆxyzj , µˆ
yz
j and µˆ
z
j the calibrated estimates of µj for j in A, B−A and
C −B, respectively. The quality of the calibrated estimates of µj depends on
how accurate the estimates of the structural parameters are, which further
depends on n, the number of genes in A. The properties of µˆxyzj , µˆyzj and µˆzj
as n goes to ∞ are given in the following proposition.
Proposition 2. Assume the functional system of the ME models is true
and the limits in (2.3) exist.
(i) As n goes to ∞, µˆxyzj asymptotically follows the normal distribu-
tion N(µj, γA) for j ∈A, µˆyzj asymptotically follows the normal distribution
N(µj , γB−A) for j ∈ B −A, and µˆzj asymptotically follows the normal dis-
tribution N(µj, γC−B) for j ∈ C −B, where γA = (1/σ21 + β22/σ22 + β23/σ23)−1,
γB−A = (β
2
2/σ
2
2 + β
2
3/σ
2
3)
−1 and γC−B = (β
2
3/σ
2
3)
−1.
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(ii) The variances of µˆxyzj , µˆ
yz
j and µˆ
z
j admit the following first order
expansions:
Var(µˆxyzj )≈ γA + n−1ωA(θ, µj) for j ∈A,(2.5a)
Var(µˆ
(yz)
j )≈ γB−A + n−1ωB−A(θ, µj) for j ∈ B −A,(2.5b)
Var(µˆzj)≈ γC−B + n−1ωC−B(θ, µj) for j ∈ C −B,(2.5c)
where the explicit expressions of ωA(θ, µj), ωB−A(θ, µj) and ωC−B(θ, µj) are
given in the supplementary material [Sun, Kuczek and Zhu (2014)], Sec-
tion S.3.
From Proposition 2, as n goes to ∞, the calibrated estimates µˆxyzj , µˆyzj
and µˆzj are asymptotically unbiased estimates of µj for j in A, B −A and
C − B, respectively. The variances of the calibrated estimates do not con-
verge to zero asymptotically, instead, they converge to γA, γB−A and γC−B,
respectively. When n is sufficiently large, the second terms in (2.5a), (2.5b)
and (2.5c) are negligible, and the variances of the calibrated estimates of µj
for j in A, B −A and C − B can be approximated by γA, γB−A and γC−B,
respectively. When n is small or moderate, the second terms in the above
expansions may not be negligible.
It is clear that γB−A is larger than γA, and γC−B is larger than γB−A and
γA. The order implies that when n is sufficiently large, the calibrated esti-
mate of µj based on only the measurements of RNA-Seq is less accurate than
the calibrated estimate of µj based on the RNA-Seq and microarray mea-
surements, which, further, is less accurate than those calibrated estimates
based on all three platforms.
We further compare the three types of calibrated estimates with the qRT-
PCR measurement Xj , microarray measurement Yj and the RNA-Seq mea-
surement Zj . Note that Xj , which is presumably the most accurate mea-
surement among Xj , Yj and Zj , is an unbiased estimate of µj , and its
reproducibility is σ21 . Because γA is less than σ
2
1 , µˆ
xyz
j is more accurate than
Xj when n is sufficiently large. Therefore, by combining the measurements
from all three platforms, we can obtain a more accurate estimate of the
expression level of gene j. Because γB−A is less than either of σ
2
2/β
2
2 and
σ23/β
2
3 , which are the reproducibilities of Yj and Zj , respectively, µˆ
yz
j is more
accurate than Yj and Zj when n is large. γC−B is equal to σ
2
3/β
2
3 , which is
the reproducibility of Zj . Therefore, µˆ
z
j has the same reproducibility as the
RNA-Seq measurement Zj . The advantage for using µˆ
z
j instead of Zj is that
µˆzj is in the same scale as µˆ
xyz
j and µˆ
yz
j so that the calibrated estimates in
C − B are scale compatible with those in A and B −A.
The calibrated estimates {µˆxyzj : j ∈ A}, {µˆyzj : j ∈ B − A} and {µˆzj : j ∈
C − B} can also be considered gene expression measurements normalized
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by the qRT-PCR platform. As discussed above, the standard errors of these
three types of calibrated estimates are different. Let ϕj,A, ϕj,B−A and ϕj,C−B
denote the first order expansions of the variances of µˆxyzj , µˆ
yz
j and µˆ
z
j in
(2.5a), (2.5b) and (2.5c), respectively. By replacing the structural parameters
with their corresponding estimates, we obtain the estimated variances and
standard errors of the three types of calibrated estimates, which are ϕˆj,A and√
ϕˆj,A, ϕˆj,B−A and
√
ϕˆj,B−A, and ϕˆj,C−B and
√
ϕˆj,C−B, respectively. When
used for gene expression analysis such as detecting differentially expressed
genes, both the calibrated estimates and their standard errors need to be
used.
3. Simulation. An extensive simulation study was conducted to evalu-
ate the performance of the proposed calibration method. In this section
we present the simulation results under the single-lab scenario. We first re-
port the simulation results on the accuracy of the calibrated estimates or
calibrated expression levels, and then we present the performance of the cal-
ibrated estimates when used in gene differential expression (DE) analysis.
3.1. Accuracy of estimates. In this section we report the simulation re-
sults for three settings of the system of ME models under the single-lab
scenario. The structural parameters of the three settings are listed in Ta-
ble 1. Setting 1 is set to resemble the results from real data analysis in
Section 4. In setting 2 the reproducibilities of microarray and RNA-Seq
are mildly worse than that of qRT-PCR technology; and in setting 3 the
reproducibilities of microarray and RNA-Seq are much worse that that of
qRT-PCR. The incidental parameters (i.e., µj ’s) for each model setting were
randomly drawn from N(0,25). For each model setting, we independently
generated a training data set of 300 genes and a testing data set of 1000
genes. Both data sets contain the measurements of the genes by all three
platforms. The measurements of the first n genes in the training set were
used to estimate the structural parameters (n was varied from 20 to 300),
and then the three types of calibrated estimates of the expression levels of
the genes in the testing set were obtained. For each combination of model
Table 1
The settings of model parameters in simulation study
Intercept Slope Reproducibility
α2 α3 β2 β3 σ
2
1 σ
2
2 σ
2
3
Setting 1 9 5 0.75 1 0.8 1.2 1
Setting 2 0.02 0.2 0.9 0.95 0.5 1 0.75
Setting 3 −5 5 1.3 1.2 0.2 1 1.2
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Fig. 1. Variances of calibrated estimates of gene expression levels. The bottom three
curves (plotted in circles) are for {Var(µˆxyzj )}, the middle three curves (plotted in crosses)
are for {Var(µˆyzj )} and the top three curves (plotted in triangles) are for {Var(µˆ
z
j )}, with
n= 20,50,300, respectively.
setting and n, this procedure was repeated 200 times to calculate the MSEs
of the estimates for the purpose of performance evaluation and comparison.
We first examine and compare the variances of the calibrated expres-
sion levels µˆxyzj , µˆ
yz
j and µˆ
z
j . Recall that Var(µˆ
xyz
j ) = γA + n
−1ωA(θ, µj).
When n is large, γA is the dominant term and the other higher order terms
are negligible; but when n is moderate (e.g., n ∈ [20,50]), the second term
n−1ωA(θ, µj) is not negligible. Further notice that γA depends on the struc-
tural parameters only, but n−1ωA(θ, µj) also depends on the incidental pa-
rameters, particularly (µj − µ¯)2 as shown in the supplementary material
[Sun, Kuczek and Zhu (2014)], Section S.3. This implies that the variance
of µˆxyzj increases as µj deviates away from the mean µ¯ when n is moderate.
The variances of µˆyzj and µˆ
z
j behave in the same way as the variance of µˆ
xyz
j .
Figure 1 from bottom to top shows the scatter plots of the sample vari-
ances of µˆxyzj , µˆ
yz
j and µˆ
z
j versus the incidental parameters µj for the first
model setting and three different sizes of training data subsets (black for
n = 20, blue for n = 50, and red for 300). For convenience, we refer to the
curve generated by plotting the variance of a type of estimate against the
incidental parameter as the variance curve of the type of estimate. The bot-
tom three curves are the variance curves of µˆxyzj for n = 20,50 and 300,
respectively, the middle three curves are those of µˆyzj , and the top three
curves are those of µˆzj .
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Fig. 2. Average MSEs of original measurements and calibrated estimates. Plots (a), (b)
and (c) are for model settings 1, 2 and 3, respectively.
For each type of estimate, the variance curve for n= 20 is above that for
n= 50, which is above that for n= 300, indicating that as n increases, the
variance of the respective estimate decreases. Furthermore, all three variance
curves for n= 20 demonstrate a stronger quadratic pattern than those for
n= 50 and n= 300, indicating their dependence on (µj − µ¯)2. The variance
curves for n= 50 show a much mitigated quadratic pattern, and the variance
curves for n = 300 become flat. Comparing the variance curves, it is clear
that under the same n, the variance curve of µˆxyzj is lower than that of µˆ
yz
j ,
which is lower than that of µˆzj , indicating that, in terms of accuracy, the
order of the three types of estimates, from the best to the worst, is µˆxyzj , µˆ
yz
j
and µˆzj . These results confirm the properties of the variances of the three
types of estimates discussed in Section 2.
We further examine the average MSEs of the three types of calibrated
estimates over all of the genes in the testing data set. For convenience in
discussion, we refer to the scatter plot of the average MSE of a type of
estimate over all of the genes in the testing data set versus the training
data size n as the aMSE curve of the type of estimate. Note that Xj is also
an unbiased estimate of µj , and we also compare the average MSEs of Xj
with the three types of estimates. Figure 2 demonstrates the aMSE curves
of the three types of estimates {µˆxyzj }, {µˆyzj } and {µˆzj} as well as that of the
original qRT-PCR measurements {Xj}. Plots (a), (b) and (c) in Figure 2
from the left panel to the right panel correspond to the three model settings
given in Table 1, respectively.
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The aMSE curves of {Xj} are flat because they do not depend on n. Over-
all, the aMSE curves of {µˆxyzj }, {µˆyzj } and {µˆzj} decrease as n increases, and
they become flat after n is greater than 100, indicating that the structural
parameters are accurately estimated and the benefit of further increasing n
in the training data set becomes negligible.
In all of the plots, the aMSE curves of {µˆxyzj } are always the lowest,
indicating that {µˆxyzj } give the most accurate quantification of the gene
expression levels. The aMSE curves of {µˆyzj } are always below the aMSE
curves of {µˆzj}, indicating that {µˆyzj } is more accurate than {µˆzj}. However,
the aMSE curve of {µˆyzj } is not always below that of {Xj}. Plots (a), (b)
and (c) demonstrate three different cases where when n is sufficiently large
(e.g., ≥100), the aMSE curves of {µˆyzj } are below, close to and above that
of {Xj}. In general, the performance of {µˆyzj } relative to {Xj} depends on
the model settings. In all of the plots, the aMSE curves of {µˆzj} are al-
ways above that of {Xj}, indicating that the calibrated estimate based on
RNA-Seq measurement alone cannot outperform the qRT-PCR measure-
ment.
As discussed in Section 2, the structural parameters are fundamentally
different from the incidental parameters. As n increases, the estimates of
the structural parameters will converge to their respective targets as shown
in Proposition 1. The simulation results about the structural parameters
can be found in the supplementary material [Sun, Kuczek and Zhu (2014)],
Section S.4.
3.2. Differential expression. In this section we report the simulation
study on the performance of calibrated estimates when used in DE anal-
ysis. In order to make the simulation study convincing, we simulated the
RNA-Seq data from a popularly used simulator called the Flux Simulator
[Griebel et al. (2012)]. The Flux Simulator mimics the pipeline of RNA-Seq
experiments and generates RNA-Seq short reads. It allows researchers to
investigate the properties of RNA-Seq data and the analysis tools in silico.
In this study, we considered two biological conditions, which are referred to
as conditions 1 and 2. Totally, 5000 genes were considered, and among them
500 genes were set to be differentially expressed. Let µ1j and µ2j denote the
log-2 values of the true expression levels of gene j under the two conditions,
respectively, and dj = µj1 − µj2 the difference between µ1j and µ2j . Under
condition 1, µ1j ’s were randomly assigned by the Flux Simulator using its
default setting. When gene j is not differentially expressed between the two
conditions, we set dj to be 0; otherwise, dj is randomly generated from the
uniform distribution on [−2,−0.5] ∪ [0.5,2]. Then under condition 2, µ2j ’s
were set to be µ1j +dj . For each biological sample, 5 million reads were gen-
erated and mapped back to the reference genome. Finally, the log-2 RPKM
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values were calculated and used as the RNA-Seq expression measurements.
qRT-PCR and microarray data were generated from the system of ME mod-
els, with the true expression levels on the two conditions set the same as
those used for the RNA-Seq data. The structural parameters related to qRT-
PCR and microarray (i.e., α2, β2, σ1 and σ2) were set the same as setting 1
in Table 1. We generated qRT-PCR data for 500 genes and microarray data
for 3000 genes. Therefore, in this simulation study, there are 500 genes in
set A, 3000 genes in set B, and 5000 gene in set C.
After generating the expression measurements, we applied the system of
ME models for each biological condition. The calibrated expression levels
and their variances are µˆxyzj and ϕˆj,A, µˆ
yz
j and ϕˆj,B−A, and µˆ
z
j and ϕˆj,C−B,
for j ∈A, B −A and C −B, respectively. In what follows, for convenience, we
do not further distinguish the notation for these three types of calibrated
estimates. Instead, we use µˆj1 and µˆj2 to denote the calibrated expres-
sion levels of gene j under condition 1 and condition 2, respectively, and
use ϕˆj1 and ϕˆj2 to denote the estimated variances of µˆj1 and µˆj2, respec-
tively.
We performed DE analysis for the two conditions using the z-test based on
the RNA-Seq measurements (Zj ’s) and the calibrated measurements (µˆj ’s)
separately, and compared the results. When performing the z-test based on
the calibrated measurements for gene j, the p-value for testing H0 :µj1 = µj2
was
pj = 2P
(
Z >
|µˆj1 − µˆj2|√
ϕˆj1 + ϕˆj2
)
,(3.1)
where Z follows the standard normal distribution. Based on the calcu-
lated p-values, the standard Benjamini–Hochberg procedure [Benjamini and
Hochberg (1995)] was used to identify differentially expressed genes at a
given false discovery rate (FDR). The z-test based on the RNA-Seq mea-
surements was similarly conducted.
Figure 3 depicts the Receiver Operator Characteristic (ROC) curves com-
paring the performances of the calibrated expression measurements and the
RNA-Seq expression measurements in DE analysis. The ROC curve of the
calibrated expression levels (black line) is above that of the RNA-Seq ex-
pression measurements (red line), indicating the DE results based on the cal-
ibrated expression measurements have higher true positive rate than those
based on the uncalibrated RNA-Seq expression measurements at any level
of false positive rate. For example, at the false positive rate level of 0.05, the
true positive rate of the uncalibrated RNA-Seq measurements was 0.565,
while that of the calibrated expression measurements was 0.641. Therefore,
the calibrated expression measurements outperform the uncalibrated RNA-
Seq measurements in this example.
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Fig. 3. ROC curves of DE analysis based on the calibrated expression levels and the
RNA-Seq measurements.
4. Application and results.
4.1. Data sets. We applied the system of ME models to analyze the qRT-
PCR, RNA-Seq and microarray gene expression data of two RNA samples,
namely, the human brain reference RNA sample (or, in short, the Brain
sample) and the human universal reference RNA sample (or the UHR sam-
ple), generated by the Microarray Quality Control (MAQC) and Sequencing
Quality Control (SEQC) projects.
The qRT-PCR data were generated by one single lab using TaqMan R©
Gene Expression Assays and can be downloaded from Gene Expression Om-
nibus (GEO) with the series number GSE5350 (ftp://ftp.ncbi.nih.gov/
pub/geo/DATA/supplementary/series/GSE5350/). The qRT-PCR data
were normalized by the delta–delta Ct method and originally contain the
qRT-PCR measurements of 1001 genes; see the supplementary material Sec-
tion S1.2 of Bullard et al. (2010) for detailed information. Among the 1001
genes, 7 genes have multiple entries with distinct expression values but under
the same RefSeq ID. To avoid ambiguity, these genes were removed. Each
gene has 4 technical replicates for each of the UHR and Brain samples.
The RNA-Seq data include measurements generated from two RNA-Seq
experiments conducted in two different labs using the Illumina Genome An-
alyzer. The data from the first lab [Bullard et al. (2010)] can be downloaded
from the NCBI Sequence Read Archive (SRA) (http://www.ncbi.nlm.nih.
gov/sra/) under the accession number SRA010153, and the data from the
second lab can be downloaded from the same website under the accession
number SRA008403. For convenience, we will use the accession numbers to
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refer to these two data in the rest of the article. The RPKM value is calcu-
lated lane-by-lane for each gene. For each of the Brain and UHR samples,
those genes that received no reads in at least one lane of the two RNA-Seq
experiments were excluded. See the supplementary material [Sun, Kuczek
and Zhu (2014)], Section S.7, for more information about the two RNA-Seq
data sets.
The microarray data were generated by five different microarray exper-
iments conducted in five different labs using Affymetrix U133 Plus2.0. For
convenience, we label the labs as MA1 to MA5 in the rest of the article. The
original probe-level data can be downloaded from Gene Expression Omnibus
(GEO) with the series number GSE5350 (ftp://ftp.ncbi.nih.gov/pub/
geo/DATA/supplementary/series/GSE5350/). Data from each lab have 5
replicates for both UHR and Brain samples, and was normalized using the
PLIER [Affymetrix Inc. (2005)] method. Detailed information about these
data sets can be found in the website of the MAQC projects (http://www.
fda.gov/). For each replicate in each lab, the average probe-level measure-
ment of a gene is considered the gene’s expression level intensity.
We integrated the three different types of gene expression data as follows.
First, the log-2 transformation was applied to all three types of gene expres-
sion data. Then for each gene and each lab, the mean measurement across
technical replicates is used as the gene’s expression value. Furthermore, we
exclude genes with extremely low or extremely high expression levels (i.e.,
those with qRT-PCR expression measurements below −6 or above 4 in log-2
scale) in A; the remaining genes in A are used to estimate the structural
parameters. For the Brain sample, there are 409 genes with expression data
from all three platforms (A), 6419 genes with only RNA-Seq and microarray
measurements (B −A), and 5949 genes with only RNA-Seq measurements
(C − B); and for the UHR sample, there are 477 genes with measurements
by all three platforms (A), 7187 genes with measurements only by RNA-
Seq and microarray (B − A), and 6892 genes with only measurements by
RNA-Seq (C − B).
Two schemes were used to analyze the integrated data. First, we consid-
ered the single-lab scenario, in which each platform has data from one lab.
In total, there are ten possible combinations, and we applied the system of
ME models (2.1a)–(2.1c) to each combination. The analysis results of in-
dividual combinations were similar, and we report only the results for the
combination that includes the RNA-Seq data from SRA010153 and the mi-
croarray data from MA1. Second, we applied the system of ME models for
the multi-lab scenario to analyze the entire data set for each RNA sample.
Due to limited space, the results from the multi-lab scenario are presented
and briefly discussed in the supplementary material [Sun, Kuczek and Zhu
(2014)], Section S.8.
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4.2. Diagnostics of model assumptions. The system of ME models
(2.1a)–(2.1c) imposes the normality and homoscedasticity assumptions on
the measurement errors. We checked these assumptions using genes in A.
After the system of ME models was fitted, we calculated the residuals by
e1j =Xj − µˆj , e2j = Yj − αˆ2 − βˆ2µˆj and e3j = Zj − αˆ3− βˆ3µˆj corresponding
to the measurement errors due to the qRT-PCR, microarray and RNA-Seq
platforms, respectively. To check the normality assumption, we generated the
QQ plots for the residuals and did not detect significant violation of the as-
sumption. To check the homoscedasticity assumption, we generated residual
plots and constructed approximate 95% confidence intervals of the Box–Cox
transformation. Because the diagnostic results are similar for the two RNA
samples, we present only those from the UHR sample as an example. The
residual plots corresponding to the qRT- PCR, microarray and RNA-Seq
platforms are presented in Figure S3 in the supplementary material [Sun,
Kuczek and Zhu (2014)], Section S.8. The plots do not demonstrate strong
heteroscedastic patterns. The 95% confidence intervals of Box–Cox transfor-
mation for the residuals from the three platforms are presented in Figure S4
in the supplementary material [Sun, Kuczek and Zhu (2014)], Section S.8.
The confidence intervals corresponding to the qRT-PCR and RNA-Seq plat-
forms both contain 1, and 1 is on the boundary of the confidence interval
corresponding to the microarray platform. These results together indicate
that there does not exist significant violation of the homoscedasticity as-
sumption imposed on the platform measurement errors.
4.3. Structural parameters. The estimates of the structural parameters
for the Brain and UHR samples are given in Table 2. The standard errors
of the estimates are also reported in parentheses in the table. The estimates
of the structural parameters can be used to compare the three platforms in
terms of the quality of measurements they provide.
From models (2.1a)–(2.1c), the qRT-PCR measurements are unbiased
with respect to µj ’s, and the intercepts α2 and α3 represent the shifts of
Table 2
Estimates of structural parameters using the qRT-PCR data, RNA-Seq data from
SRA010153 and microarray data from MA1
Intercept Slope Variance
αˆ2 αˆ3 βˆ2 βˆ3 σˆ
2
1 σˆ
2
2 σˆ
2
3
Brain 8.8401 4.9405 0.7754 1.0254 0.7945 1.2407 1.0679
(0.0921) (0.1115) (0.0411) (0.0514) (0.1156) (0.0955) (0.1641)
UHR 9.1033 5.4249 0.7695 1.0009 0.6685 1.0444 0.9452
(0.0745) (0.0875) (0.0292) (0.0347) (0.0882) (0.0768) (0.1233)
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microarray and RNA-Seq measurements relative to the qRT-PCR measure-
ments. Larger absolute values of α2 and α3 indicate larger shifts. From Ta-
ble 2, αˆ2 are 8.8401 and 9.1033 in the Brain and UHR samples, respectively;
and αˆ3 are 4.9405 and 5.4249 in the Brain and UHR samples, respectively. In
both samples, αˆ2 > αˆ3, indicating that microarray measurements have larger
shifts than the RNA-Seq measurements. The slopes β2 and β3 represent the
scales of microarray and RNA-Seq measurements relative to qRT-PCR mea-
surements. From Table 2, βˆ2 are 0.7754 and 0.7695 in the Brain and UHR
samples, respectively, both of which are significantly less than 1, indicating
that the microarray measurements are in a smaller scale compared to the
qRT-PCR measurements. On the other hand, βˆ3 are 1.0254 and 1.0009 in
the Brain and UHR samples, respectively, both of which are not significantly
different from 1, indicating that the RNA-Seq measurements are in a similar
scale as the qRT-PCR measurements. The variances σ21 , σ
2
2/β
2
2 and σ
2
3/β
2
3
reflect the reproducibilities of the three platforms. Smaller value indicates
higher reproducibility. From Table 2, in the Brain sample, the three values
are 0.7945, 2.0635 and 1.0157; and in the UHR sample, the three values are
0.6685, 1.7638 and 0.9435. In both samples, σˆ21 < σˆ
2
3/βˆ
2
3 < σˆ
2
2/βˆ
2
2 , indicating
that qRT-PCR has the best reproducibility, microarray has the worst repro-
ducibility, and RNA-Seq is slightly worse than qRT-PCR but much better
than microarray.
4.4. Incidental parameters. After the estimates of the structural param-
eters were obtained, we used the formulas obtained in Section 2 to estimate
the gene expression levels, and the standard errors of the calibrated gene
expression values were also calculated. These calibrated gene expression val-
ues together with their standard errors are expected to have a higher quality
than the original measurements by the three platforms and lead to better
results in downstream gene expression analysis.
We compare the calibrated gene expression levels with their original qRT-
PCR, microarray and RNA-Seq measurements, and use the genes in the
Brain and UHR samples that have measurements by all three platforms as
an illustrative example. Because these genes have measurements by all three
platforms, all three types of calibrated estimates {µˆzj}, {µˆyzj } and {µˆxyzj }
could be calculated. Based on the theoretical and simulation results in Sec-
tions 2 and 3, {µˆxyzj } are the most accurate measurements. We plotted the
original measurements {Xj}, {Yj} and {Zj} as well as the calibrated mea-
surements {µˆyzj } against {µˆxyzj }, and presented the plots in Figures 4 and 5
for the Brain and UHR sample, respectively. Because {µˆzj} are the linear
transformation of the original RNA-Seq measurements {Zj}, the plot of
{µˆzj} versus {µˆxyzj } had the same appearance as the plot of {Zj} versus
{µˆxyzj } and thus was not presented. In each plot, the correlation coefficient
between the two plotted measurements was calculated and reported.
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Fig. 4. Scatter plots of the measurements by microarray, RNA-Seq, qRT-PCR and µˆyz
versus µˆxyz on A in the Brain sample.
From Figure 4, in the Brain sample, in terms of the linear correlation coef-
ficient with the best measurements {µˆxyzj }, microarray is the worst (0.8112)
and qRT-PCR is the best (0.9403) among the three platforms. This is consis-
tent with the findings reported in the literature that in terms of the quality
of the gene expression data produced by the three platforms, qRT-PCR is
most accurate and microarray is least accurate. The calibrated expression
levels {µˆyzj } have a higher correlation coefficient with {µˆxyzj } (0.9551) than
the qRT-PCR, microarray and RNA-Seq measurements. In the UHR sam-
ple, in terms of the linear correlation coefficient with the best measurements
{µˆxyzj }, again microarray is the worst (0.8553) and qRT-PCR is the best
(0.9583) among the three platforms. The calibrated expression levels {µˆyzj }
have a higher correlation coefficient with {µˆxyzj } (0.9645) than qRT-PCR,
microarray and RNA-Seq measurements.
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Fig. 5. Scatter plots of the measurements by microarray, RNA-Seq, qRT-PCR and µˆyz
versus µˆxyz on A in the UHR sample.
4.5. Gene differential expression. To demonstrate that calibrated ex-
pression levels can lead to better gene differential expression results, we used
the RNA-Seq measurements (Zj ’s) and the calibrated measurements (µˆj ’s),
separately, to perform gene DE analysis for the Brain and UHR samples.
We carried out the DE analysis using the same z-test procedure as de-
scribed in Section 3.2. Controlling the FDR at 0.01, the numbers of identified
genes by the two types of measurements are reported in Table 3. In total, 331
genes were detected to be differentially expressed in the UHR and Brain sam-
ples using the calibrated expression measurements, whereas only 158 genes
were detected using the original RNA-Seq measurements. These two groups
of genes share 153 genes. Therefore, the calibrated expression measurements
led to the detection of almost all the genes (153 out of 158 genes) detected
by the original RNA-Seq measurements. In addition, the former detected
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Table 3
Numbers of differentially expressed genes detected
by calibrated estimates and RNA-Seq
measurements
Gene set Calibration RNA-Seq Overlap
A 36 9 9
B −A 192 60 60
C − B 103 89 84
Total 331 158 153
173 more genes than the latter. The total number of genes detected by each
type of measurements was further broken down according to whether a gene
belongs to A, B −A or C − B, and the results are also reported in Table 3.
From the table, 27, 132 and 14 more genes were detected by the calibrated
expression measurements in A, B −A and C − B, respectively, than by the
original RNA-Seq measurements. In this case, there does not exist a gold
standard to further verify the selected genes by the calibrated expression
measurements and the RNA-Seq expression measurements. However, based
on the simulation study in Section 3.2, we believe that the DE analysis based
on the calibrated measurements has higher true positive rate and can lead
to more discoveries than the uncalibrated RNA-Seq measurements. A list of
the identified genes by the calibrated expression measurements is given in
the supplementary material [Sun, Kuczek and Zhu (2014)], Section S.9.
5. Discussion. A system of functional measurement error (ME) models
was proposed to calibrate the microarray and RNA-Seq measurements of
gene expression levels by qRT-PCR. Due to limited space, the design issue
of the proposed approach was not discussed in this article. The success of
the proposed approach hinges on the genes that are measured by all three
platforms, and the major bottleneck is the relative low throughput of the
qRT-PCR platform. Therefore, the design issue is centered on the qRT-PCR
platform with respect to two questions. The first question is how many genes
should to be measured by qRT-PCR, and the second question is which genes
should be measured. For the first question, based on the theoretical, sim-
ulation and real data application results in this article, it seems that at
least 150 genes are needed to ensure that the bias and variances (i.e., the
structural parameters) can be accurately estimated and the calibrated gene
expression levels (i.e., the incidental parameters) can reach their best pos-
sible accuracy. Vendors of the qRT-PCR platform such as Life Technologies
now offer assays and services to measure a sufficiently large number of genes
simultaneously. This makes our proposed approach feasible in practice. For
the second question, based on our theoretical results (e.g., Proposition 1),
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the true expression levels of the genes selected to be measured by qRT-PCR
should be as spread out as possible. These two questions and the design
issue in general will be addressed in a future publication.
As discussed in the Introduction, RNA-Seq data are also found to be
subject to excessive variability and various methods have been proposed to
normalize RNA-Seq data. In this article, only the RPKM method and the
resulting RPKM measurements were used as the RNA-Seq measurements.
Clearly, other normalization methods and their resulting measurements can
also be considered. The variance component due to the RNA-Seq platform
estimated under the multi-lab scenario (i.e., ς22 ) in this article corresponds
to the RPKM method. If another normalization method (e.g., the “mseq”
method) is used, then ς22 will correspond to that normalization method.
Therefore, the system of ME models can be used to compare different nor-
malization methods.
The functional system of ME models of order 3 can be extended to that
of order p > 3, and the two-step approach to parameter estimation can also
be extended in a straightforward manner. In this article, the bias of the
measurement of a platform is assumed be a linear function of the true ex-
pression level. In general, nonlinear models or even nonparametric models
can be considered. Furthermore, covariates can also be incorporated into the
system of functional ME models. These possible extensions of the proposed
approach will be investigated in the near future.
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